Enovis Co. (NYSE:ENOV – Get Rating) CFO Phillip Benjamin (Ben) Berry sold 645 shares of Enovis stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $54.17, for a total value of $34,939.65. Following the transaction, the chief financial officer now directly owns 20,223 shares of the company’s […]
Enovis (NYSE:ENOV – Get Rating) and Avanos Medical (NYSE:AVNS – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, profitability, risk, earnings and dividends. Volatility & Risk Enovis has a beta of 2.02, meaning that […]
Enovis Co. (NYSE:ENOV – Get Rating) was the recipient of a significant decrease in short interest in May. As of May 15th, there was short interest totalling 1,810,000 shares, a decrease of 6.7% from the April 30th total of 1,940,000 shares. Approximately 3.7% of the company’s stock are sold short. Based on an average daily […]
Enovis Co. (NYSE:ENOV – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the ten research firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year target price among […]
Shares of Enovis Co. (NYSE:ENOV – Get Rating) have been assigned a consensus recommendation of “Moderate Buy” from the ten analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 12 month price […]